Abbonarsi

ULTRASOUND-GUIDED TRANSTHORACIC BIOPSY OF THE CHEST - 06/09/11

Doi : 10.1016/S0033-8389(05)70166-4 
Pan-Chyr Yang, MD, PhD *

Riassunto

Advances in technology have greatly improved the imaging capabilities of ultrasound (US). This article summarizes the current applications of US as a diagnostic tool in chest diseases. By scanning through the acoustic window, US is a very reliable and efficient tool for evaluating lesions of the chest wall, pleural cavity, peridiaphragm, mediastinum, hilum, and peripheral lungs. A precise puncture transducer can be used to perform US-guided transthoracic needle biopsy (TNB) with real-time visualization of the biopsy needle and the lesion. The accuracy of US-guided TNB for peripheral pulmonary nodules, chest wall lesions, and mediastinal tumors is 88% to 100%. US-guided TNB is also useful for histologic diagnosis of tumors causing superior vena cava (SVC) syndrome, Pancoast's tumors, pulmonary consolidation of unknown etiology, and tumors with obstructive pneumonitis. Moreover, transthoracic needle aspiration under US guidance can provide adequate specimens for microbiologic diagnosis of lung abscesses, necrotizing pneumonia, and parapneumonic effusions. Color Doppler imaging further extends the diagnostic spectrum of US, allowing the hemodynamics and neovascularization of a pulmonary lesion to be assessed noninvasively. Pulmonary arteriovenous malformations, pulmonary sequestration, and pulmonary infarctions can be diagnosed easily with color Doppler US. The color Doppler US puncture guiding device can improve the safety of US-guided TNB by simultaneously displaying blood vessel information, the needle shaft, and the puncture route. US examination and US-guided TNB have become indispensable diagnostic techniques for various chest diseases.

TNB with imaging guidance is a well-established technique for the diagnosis of focal pulmonary lesions.6, 22 CT and biplane fluoroscopy are the most common imaging modalities used to guide TNB. With advances in imaging capabilities, biopsy techniques, and cytopathology, CT- and fluoroscopy-guided TNB can now provide extremely high diagnostic yields (sensitivity 80% to 95%) and are relatively safe.6, 21 These diagnostic modalities may be time-consuming, however, especially for small peripheral pulmonary lesions, and carry the risk of excessive exposure to radiation.

Recently, rapid advances in transducer design, signal processing, and Doppler technology have greatly improved the imaging quality of US. With the development of a precise puncture-guiding device, US has proved to be a reliable, efficient, and informative imaging modality for evaluation of a wide variety of complicated clinical problems associated with chest diseases.12, 26, 32, 33, 35, 36, 37, 38, 39, 40, 41, 43 It can also be used effectively to guide TNB and other interventional procedures in the thorax.1, 2, 5, 8, 13, 19, 28, 29, 30, 31, 34 This article presents an overview of the state-of-art applications of US-guided transthoracic biopsy in chest diseases including indications and contraindications, imaging techniques, biopsy procedures, diagnostic spectrum and sensitivity, potential complications, and advantages and limitations.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Pan-Chyr Yang, MD, PhD, Department of Internal Medicine, National Taiwan University Hospital, Number 7, Chung-Shan South Road, Taipei 100, Taiwan, Republic of China, e-mail: pcyang@ha.mc.ntu.edu.tw


© 2000  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 38 - N° 2

P. 323-343 - marzo 2000 Ritorno al numero
Articolo precedente Articolo precedente
  • CT FLUOROSCOPY FOR THORACIC INTERVENTIONAL PROCEDURES
  • Charles S. White, Cristopher A. Meyer, Philip A. Templeton
| Articolo seguente Articolo seguente
  • IMAGE-GUIDED MANAGEMENT OF COMPLICATED PLEURAL FLUID COLLECTIONS
  • Jeffrey S. Moulton

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.